LIVE WEBINAR:

Drug design trends in the age of AI 

September 14, 2023 at 8:00AM (PDT), 11:00AM (EDT), 16:00 (BST)

Don't miss this opportunity to explore the intriguing world of computer-guided drug design as we compare two innovative methodologies: fragment-based drug design and full molecule-based drug design. Our esteemed panelists will delve into these two approaches' strengths, limitations, and future prospects while uncovering potential synergies.

Barry Bunin, Ph.D. CEO, Collaborative Drug Discovery	Eric Martin, Ph.D. Director, Computational Chemistry, Novartis	Daniel Erlanson, Ph.D SVP of Innovation & Discovery, Frontier Medicines

Speaker biography

Discussion topics will include:

• How is the trajectory of modeling on drug discovery different than on language (i.e. LLM)
• Compare and contrast full-molecule and fragment SAR, and when to use each approach

• How has the development of covalent drugs impacted fragment vs whole molecule drug discovery

Enter your email address to reserve your FREE webinar seat now. 

Can't make it to the live webinar? Register to receive link to the on-demand recording.